Hur JY - Search Results

1

Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma.

Oh IJ, Hur JY, Park CK, Kim YC, Kim SJ, Lee MK, Kim HJ, Lee KY, Lee JC, Choi CM. Oh IJ, et al. Among authors: hur jy. Clin Lung Cancer. 2018 Sep;19(5):e775-e781. doi: 10.1016/j.cllc.2018.05.018. Epub 2018 Jun 5. Clin Lung Cancer. 2018. PMID: 30149884

2

Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung Cancer.

Rho JK, Lee IY, Choi YJ, Choi CM, Hur JY, Koh JS, Lee J, Suh BC, Song HJ, Salgaonkar P, Lee J, Lee J, Jung DS, Kim SY, Woo DC, Baek IJ, Lee JY, Ha CH, Sung YH, Kim JK, Kim WS, Song JS, Kim CH, Bivona TG, Lee JC. Rho JK, et al. Among authors: hur jy. Cancer Res. 2017 Mar 1;77(5):1200-1211. doi: 10.1158/0008-5472.CAN-16-2432. Epub 2017 Jan 12. Cancer Res. 2017. PMID: 28082405 Free PMC article.

3

Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.

Park S, Hur JY, Lee KY, Lee JC, Rho JK, Shin SH, Choi CM. Park S, et al. Among authors: hur jy. Clin Chem Lab Med. 2017 Aug 28;55(10):1489-1495. doi: 10.1515/cclm-2016-0302. Clin Chem Lab Med. 2017. PMID: 28195541

4

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non-Small Cell Lung Cancer Patient.

Lee JS, Hur JY, Kim HJ, Lee KY, Kim WS. Lee JS, et al. Among authors: hur jy. J Thorac Oncol. 2017 Nov;12(11):e179-e181. doi: 10.1016/j.jtho.2017.07.016. J Thorac Oncol. 2017. PMID: 29074208 Free article. No abstract available.

5

Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report.

Park CK, Hur JY, Choi CM, Kim TO, Cho HJ, Shin HJ, Lim JH, Choi YD, Kim YC, Oh IJ. Park CK, et al. Among authors: hur jy. J Korean Med Sci. 2018 Jan 1;33(1):e7. doi: 10.3346/jkms.2018.33.e7. J Korean Med Sci. 2018. PMID: 29215816 Free PMC article.

6

Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients.

Hur JY, Kim HJ, Lee JS, Choi CM, Lee JC, Jung MK, Pack CG, Lee KY. Hur JY, et al. Mol Cancer. 2018 Jan 27;17(1):15. doi: 10.1186/s12943-018-0772-6. Mol Cancer. 2018. PMID: 29374476 Free PMC article. Review.

7

Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.

Lee JS, Hur JY, Kim IA, Kim HJ, Choi CM, Lee JC, Kim WS, Lee KY. Lee JS, et al. Among authors: hur jy. BMC Cancer. 2018 Dec 10;18(1):1236. doi: 10.1186/s12885-018-5138-3. BMC Cancer. 2018. PMID: 30526536 Free PMC article.

8

CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.

Hur JY, Kim HR, Lee JY, Park S, Hwang JA, Kim WS, Yoon S, Choi CM, Rho JK, Lee JC. Hur JY, et al. Cell Oncol (Dordr). 2019 Aug;42(4):449-458. doi: 10.1007/s13402-019-00434-2. Epub 2019 Mar 5. Cell Oncol (Dordr). 2019. PMID: 30838525

9

Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid from treatment-naive non-small cell lung cancer patients.

Hur JY, Lee JS, Kim IA, Kim HJ, Kim WS, Lee KY. Hur JY, et al. Transl Lung Cancer Res. 2019 Dec;8(6):1051-1060. doi: 10.21037/tlcr.2019.12.16. Transl Lung Cancer Res. 2019. PMID: 32010582 Free PMC article.

10

Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort study.

Ko YH, Kim SJ, Kim WS, Park CK, Park CK, Suh YG, Eom JS, Cho S, Hur JY, Hwang SH, Myong JP. Ko YH, et al. Among authors: hur jy. Korean J Intern Med. 2020 May;35(3):692-702. doi: 10.3904/kjim.2019.283. Epub 2020 Feb 19. Korean J Intern Med. 2020. PMID: 32066220 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page